Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxelas first-line treatment for advanced gastric cancer (OGSG0402)
国際学会発表
A phase II study of systemic chemotherapy with TS-1 combined with cisplatin followed by surgery in advanced gastric cancer (OGSG0004)
A randomized controlled trial to evaluate the effect of preoperative enteral immunonutrition on the surgical site infection after total gastrectomy（OGSG0507）
Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG0604)
Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer（OGSG0402）
Phase II study of docetaxel and cisplatin and fluorouracil for metastatic esophageal cancer（OGSG0403）
Phase I study of S-1, cisplatin, and paclitaxel in patients with advanced gastric cancer（OGSG0703）
Phase II study of weekly paclitaxel as third-line chemotherapy for advanced or recurrent gastric cancer（OGSG0602）
Phase II trial of S-1 for elderly patients over 75 years with advanced gastric cancer as first-line treatment（OGSG0404）
Phase III Trail of perioperative alone compared with perioperative plus postoperative antimicrobial prophylaxis in gastric cancer surgery (OGSG0501)